Search results :

Bromocriptine

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: G02CB01, N04BC01

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11
Nausea postmarketing — 7% - 49% x x x x x x x x x x x
Dizziness postmarketing — 8% - 17% x x x x x x x x x x x
Orthostatic hypotension postmarketing — 6% x x x x x x x x x x
Lightheadedness 5% x x x x x x x
Abdominal cramps 4% x x x x x x x x
Anorexia 4% x x x x x x x x x x
Dyspepsia 4% x x x x x x x x x
Constipation postmarketing — 3% - 14% x x x x x x x x x x x
Drowsiness postmarketing, 3% x x x x x x x x x
Nasal congestion postmarketing — 3% - 4% x x x x x x x x x x
Vomiting postmarketing — 2% - 5% x x x x x x x x x x x
Vasospasm 3% x x x x x x x
Fatigue postmarketing — 1% - 7% x x x x x x x x x x x
Dermatitis atopic uncommon x
Muscle spasms uncommon x
Diarrhoea postmarketing — 0.4% - 3% x x x x x x x x x x
Cramp muscle postmarketing, 0.4% x x x x x x x
Abdominal pain postmarketing, rare x x x x x
Acromegaly postmarketing x
Alopecia postmarketing, uncommon x x x x x x x x x
Arrhythmia postmarketing, rare x x x x x x x x x x x
Mental disorder postmarketing x x x x x x x
Confusional state postmarketing x x x x x x
Connective tissue disorder postmarketing x x x x
Delusion postmarketing x x x
Type 2 diabetes mellitus postmarketing x
Disseminated intravascular coagulation postmarketing x x x x x x x
Dyspnoea postmarketing, rare x x x x x x x x x
Eye disorder postmarketing x x x x
Body temperature increased postmarketing x
Fibrosis very rare, postmarketing x x x x x
Gastrointestinal disorder postmarketing x x x x
Gastrointestinal haemorrhage postmarketing, rare x x x x x x x x x
Hallucination postmarketing x x x x x x
Headache postmarketing — 10% - 19% x x x x x x x x x x x
Cardiac disorder postmarketing x x x x
Cardiac valve disease postmarketing x
Hyperprolactinaemia postmarketing x
Hypertension postmarketing x x
Hypotension postmarketing, uncommon x x x
Cramps of lower extremities postmarketing x x x x x
Mediastinal disorder postmarketing x x x x
Myocardial infarction postmarketing x x
Nervous system disorder postmarketing x x x x
Neuroleptic malignant syndrome very rare, postmarketing x x x x x x x x
Pallor very rare, postmarketing x x x x x
Paraesthesia postmarketing, rare x x x x x x x x x x
Parkinson's disease postmarketing x
Secondary parkinsonism postmarketing x
Pathological gambling postmarketing x x x x
Pericardial effusion postmarketing, rare x x x x x x x x x x
Pericarditis postmarketing x
Pericarditis constrictive postmarketing, rare x x x x x x x x x
Pleural effusion postmarketing, rare x x x x x
Pleurisy postmarketing, rare x x x x x
Psychotic disorder postmarketing, rare x x x x x x x x x x
Pulmonary fibrosis postmarketing, rare x x x x x x x x x x
Retroperitoneal fibrosis postmarketing, rare x x x x x x x x x x
Convulsion postmarketing x x x x x x x x x x
Status epilepticus postmarketing x x x x x x x
Cerebrovascular accident postmarketing x x x
Syncope postmarketing — 0.7% x x x x x x x x x x x
Tachycardia postmarketing, rare x x x x x
Tinnitus postmarketing, rare x x x x x
Angiopathy postmarketing x x x x
Vasculitis postmarketing x x x x x x x
Dry mouth postmarketing, uncommon x x x x x x x x
Agitation postmarketing x x x x x
Oedema peripheral postmarketing, rare x x x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x
Lung infiltration postmarketing x
Gastrointestinal ulcer postmarketing, rare x x x x x
Pleural thickening postmarketing x
Hypersexuality postmarketing x x x x x x
Superior sagittal sinus thrombosis postmarketing x x x x x x x
Vision blurred postmarketing, rare x x x x
Bradycardia postmarketing, rare x x x x x x x x x
Visual disturbance postmarketing x x x x x x x x
Ear and labyrinth disorders postmarketing x x x x
Insomnia postmarketing, rare x x x x x x x x x
Sudden onset of sleep very rare, postmarketing x x x x
Malignant syndrome NOS postmarketing x
Pleural fibrosis postmarketing, rare x x x x
Somnolence postmarketing, common x x x x x x
CNS toxicity postmarketing x x x
Visual impairment rare x
Amblyopia x
Anxiety x x x x x x x x
Asthenia x x x x x x x x
Ataxia x x x x x x x x x
Blepharospasm x x x x x x x
Cerebrospinal fluid rhinorrhea x x x x x x x
Infection x
Dysphagia x x x x x x x
Delirium x x
Diabetes mellitus x
Diplopia x x
Dyskinesia x x x
Oedema x x x x x x x x x
Ergot poisoning x x x x x x x
Erythromelalgia x x x x x x x x x x
Rash x x x x x x x x x
Cardiac failure congestive x
Hypoaesthesia x
Hypoglycaemia x
Impulse-control disorder x
Libido increased x x x
Influenza x
Lethargy x x x x x x x
Nervousness x x x x x x x
Nightmare x x x x x x x x
Numbness x x x x x x x
Peptic ulcer x
Rhinitis x
Sinusitis x
Pollakiuria x x x x x x x
Urinary incontinence x x x x x x x
Urticaria x x
Syncope vasovagal x x x x x x x
Ventricular tachycardia x x x x x x x
Vertigo x x x x x x x
Urinary retention x x x x x x x
Burning sensation x x
Lassitude x x x x x x x
Abdominal discomfort x x x x x x x
Epigastric pain x x
Hallucination, visual x x x x x x x
Neurological symptom x
Gastric haemorrhage x x x
Pallor facial x x x x x x x
Taste metallic x x
Diabetic x
Psychotic episode x x
Mania x
Cold feet x x x x x x x
Laboratory test abnormal x x x x x x x
Neoplasm recurrence x x x x x x x
Binge eating x
Excessive daytime sleepiness x x
Hypotensive x x x x x x x
Sluggishness x x x x x x x
Ocular discomfort x x
Rhinorrhoea x
Paranoia x x x x x x x x x
Tingling sensation x x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

bromocriptine

Side effects:46
Source:FDA Structured Product Label

BROMOCRIPTINE / Bromocriptine, Tablet

Side effects:39
Source:Medsafe

Bromocriptine (mesylate) / Kripton

Side effects:56
Source:medicines.org.au

Bromocriptine mesylate / PARLODEL

Side effects:78
Source:medicines.org.au

Bromocriptine

Side effects:63
Source:FDA Structured Product Label

BROMOCRIPTINE

Side effects:68
Source:FDA Structured Product Label

BROMOCRIPTINE

Side effects:68
Source:FDA Structured Product Label

BROMOCRIPTINE

Side effects:68
Source:FDA Structured Product Label

BROMOCRIPTINE

Side effects:95
Source:FDA Structured Product Label

BROMOCRIPTINE

Side effects:101
Source:FDA Structured Product Label

BROMOCRIPTINE

Side effects:101
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label